These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 34104515

  • 1. The role of galectin-3 and its genetic variants in tumor risk and survival of patients with surgically resected early-stage non-small cell lung cancer.
    Terzioğlu-Uşak Ş, Horozoğlu C, Demirkol Ş, Turna A, Yaylım İ.
    Turk Gogus Kalp Damar Cerrahisi Derg; 2021 Apr; 29(2):212-222. PubMed ID: 34104515
    [Abstract] [Full Text] [Related]

  • 2. Correlations of Galectin-3 Gene Polymorphisms with Risk and Prognosis of Cervical Cancer in Chinese Populations: A Case-Control Study.
    Fang SQ, Feng YM, Li M.
    Oncol Res Treat; 2017 Apr; 40(9):533-539. PubMed ID: 28848207
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Galectin-3 rs4652 A>C polymorphism is associated with the risk of gastric carcinoma and P-glycoprotein expression level.
    Shi Y, Lin X, Chen G, Yan J, Ying M, Zheng X.
    Oncol Lett; 2017 Dec; 14(6):8144-8149. PubMed ID: 29250191
    [Abstract] [Full Text] [Related]

  • 5. Genetic variants in LGALS3 are related to lower galectin-3 serum levels and clinical outcomes in systemic sclerosis patients: A case-control study.
    Cunha EGC, de Lima CAD, Vilar KM, Nóbrega MF, Almeida AR, Pereira MC, Dantas AT, Gonçalves RSG, Rêgo MJBM, Duarte ALBP, Pitta MGDR.
    Autoimmunity; 2021 Jun; 54(4):187-194. PubMed ID: 33973825
    [Abstract] [Full Text] [Related]

  • 6. Galectin 3 (LGALS3) Gene Polymorphisms Are Associated with Biochemical Parameters and Primary Disease in Patients with End-Stage Renal Disease in Serbian Population.
    Kovacevic Z, Lazarevic T, Maksimovic N, Grk M, Volarevic V, Gazdic Jankovic M, Djukic S, Janicijevic K, Miletic Kovacevic M, Ljujic B.
    J Clin Med; 2022 Jul 04; 11(13):. PubMed ID: 35807161
    [Abstract] [Full Text] [Related]

  • 7. Assessment of Galectin-3 Polymorphism in Subjects with Chronic Chagas Disease.
    Cruz Gda S, Angelo AL, Larocca TF, Macedo CT, Noya-Rabelo M, Correia LC, Torreão JA, Souza BS, Santos RR, Soares MB.
    Arq Bras Cardiol; 2015 Nov 04; 105(5):472-8. PubMed ID: 26312551
    [Abstract] [Full Text] [Related]

  • 8. Pro64His (rs4644) Polymorphism Within Galectin-3 Is a Risk Factor of Differentiated Thyroid Carcinoma and Affects the Transcriptome of Thyrocytes Engineered via CRISPR/Cas9 System.
    Corrado A, Aceto R, Silvestri R, Dell'Anno I, Ricci B, Miglietta S, Romei C, Giovannoni R, Poliseno L, Evangelista M, Vitiello M, Cipollini M, Garritano S, Giusti L, Zallocco L, Elisei R, Landi S, Gemignani F.
    Thyroid; 2021 Jul 04; 31(7):1056-1066. PubMed ID: 33308024
    [Abstract] [Full Text] [Related]

  • 9. Galectin-3 gene (LGALS3) +292C allele is a genetic predisposition factor for rheumatoid arthritis in Taiwan.
    Hu CY, Chang SK, Wu CS, Tsai WI, Hsu PN.
    Clin Rheumatol; 2011 Sep 04; 30(9):1227-33. PubMed ID: 21475983
    [Abstract] [Full Text] [Related]

  • 10. Exploratory Assessment of Galectin-1, -3, and -9 in Non-Small Cell Lung Cancer.
    Shuster H, Funkhouser A, Allen L, Heo M, Martin JC, Edenfield WJ, Blenda AV.
    Cancers (Basel); 2024 Mar 15; 16(6):. PubMed ID: 38539500
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A genome-wide association study of circulating galectin-3.
    de Boer RA, Verweij N, van Veldhuisen DJ, Westra HJ, Bakker SJ, Gansevoort RT, Muller Kobold AC, van Gilst WH, Franke L, Mateo Leach I, van der Harst P.
    PLoS One; 2012 Mar 15; 7(10):e47385. PubMed ID: 23056639
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Genetic determinants of circulating galectin-3 levels in patients with coronary artery disease.
    Liao YH, Teng MS, Juang JJ, Chiang FT, Er LK, Wu S, Ko YL.
    Mol Genet Genomic Med; 2020 Sep 15; 8(9):e1370. PubMed ID: 32573962
    [Abstract] [Full Text] [Related]

  • 15. Serum level of galectin-9 as a potential biomarker for high risk of malignancy in dermatomyositis.
    Shih Y, Chen S, Huang J, Chen Y, Zhu Z, Zhao Q, Zhao X, Xue F, Xiang J, Chen X, Zhu X, Pan M, Wu J, Zheng J, Li H, Cao H.
    Rheumatology (Oxford); 2024 Jan 04; 63(1):251-258. PubMed ID: 37184873
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Galectin-3 and Its Genetic Variation rs4644 Modulate Enterovirus 71 Infection.
    Huang WC, Chen HL, Chen HY, Peng KP, Lee Y, Huang LM, Chang LY, Liu FT.
    PLoS One; 2016 Jan 04; 11(12):e0168627. PubMed ID: 28002441
    [Abstract] [Full Text] [Related]

  • 18. Serum galectin-3 levels in patients with psoriasis.
    Hayran Y, Allı N, Akpınar Ü, Öktem A, Yücel Ç, Fırat Oguz E, Turhan T.
    Int J Clin Pract; 2021 Oct 04; 75(10):e14545. PubMed ID: 34137138
    [Abstract] [Full Text] [Related]

  • 19. Galectin-3 genetic variants are associated with platinum-based chemotherapy response and prognosis in patients with NSCLC.
    Wu F, Hu N, Li Y, Bian B, Xu G, Zheng Y.
    Cell Oncol (Dordr); 2012 Jun 04; 35(3):175-80. PubMed ID: 22476961
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.